Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Nature Chemical Biology
|
October 27, 2022
Ligand recognition and allosteric modulation of the human MRGPRX1 receptor
Yongfeng Liu, Can Cao, Xi-Ping Huang, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 5, 2021
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
Vladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, et al.
Journal of Medicinal Chemistry
|
December 17, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo
Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo
Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Library docking for Cannabinoid-2 Receptor ligands
Moira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Journal of Medicinal Chemistry
|
July 3, 2026
Library Docking for Cannabinoid-2 Receptor Ligands
Moira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens
Jongbin Kim, Galen J Correy, Brendan W Hall, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
Elife
|
November 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Nature Chemical Biology
|
October 27, 2022
Ligand recognition and allosteric modulation of the human MRGPRX1 receptor
Yongfeng Liu, Can Cao, Xi-Ping Huang, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 5, 2021
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
Vladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, et al.
Journal of Medicinal Chemistry
|
December 17, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo
Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo
Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui, et al.
Biorxiv : the Preprint Server for Biology
|
March 27, 2026
Library docking for Cannabinoid-2 Receptor ligands
Moira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Journal of Medicinal Chemistry
|
July 3, 2026
Library Docking for Cannabinoid-2 Receptor Ligands
Moira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Biorxiv : the Preprint Server for Biology
|
January 9, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens
Jongbin Kim, Galen J Correy, Brendan W Hall, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2
Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
Elife
|
November 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2
Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy, et al.
Page
of 2